SH

Sotera Health CoNASDAQ SHC Stock Report

Last reporting period 30 Jun, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

4.718

Middle

Exchange

XNAS - Nasdaq

SHC Stock Analysis

SH

Uncovered

Sotera Health Co is uncovered by Eyestock quantitative analysis.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

20/100

Low score

Market cap $B

4.718

Dividend yield

Shares outstanding

282.42 B

Sotera Health Co. provides mission-critical sterilization, lab testing and advisory services to the medical device and pharmaceutical industries. The company is headquartered in Broadview Heights, Ohio and currently employs 3,000 full-time employees. The company went IPO on 2020-11-20. The firm operates through three segments: Sterigenics, Nordion and Nelson Labs. The Sterilization Services includes products, such as procedure kits and trays, implants, syringes, catheters, wound care products, medical protective barriers, including personal protective equipment (PPE), laboratory products and pharmaceuticals. Its lab testing and advisory services offer microbiological and analytical chemistry laboratory tests across the medical device and pharmaceutical industries. Its medical device testing services include microbiology, biocompatibility and toxicology assessments, material characterization, sterilization validation, sterility assurance. Its pharmaceutical lab testing services include microbiology, biocompatibility and toxicology assessments, extractables and leachables evaluations of pharmaceutical containers.

View Section: Eyestock Rating